Myron Elmer Essex, D.V.M., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV-1 | 19 | 2020 | 6858 | 0.520 |
Why?
|
HIV Infections | 23 | 2021 | 17342 | 0.480 |
Why?
|
Sampling Studies | 1 | 2014 | 615 | 0.430 |
Why?
|
Acquired Immunodeficiency Syndrome | 6 | 2021 | 2197 | 0.420 |
Why?
|
HIV-2 | 8 | 2000 | 156 | 0.370 |
Why?
|
Proviruses | 3 | 2006 | 313 | 0.300 |
Why?
|
Receptors, CXCR4 | 3 | 2016 | 727 | 0.230 |
Why?
|
Viral Load | 7 | 2020 | 3325 | 0.230 |
Why?
|
Receptors, HIV | 2 | 2016 | 158 | 0.210 |
Why?
|
HIV Envelope Protein gp120 | 6 | 2016 | 914 | 0.190 |
Why?
|
Botswana | 7 | 2021 | 1049 | 0.180 |
Why?
|
Acyclovir | 2 | 2011 | 267 | 0.170 |
Why?
|
Herpes Genitalis | 2 | 2011 | 149 | 0.160 |
Why?
|
Circumcision, Male | 1 | 2020 | 148 | 0.160 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 2 | 2012 | 369 | 0.150 |
Why?
|
Interferon-gamma | 2 | 2006 | 3145 | 0.150 |
Why?
|
Genes, env | 2 | 2012 | 95 | 0.140 |
Why?
|
Molecular Sequence Data | 9 | 2014 | 17630 | 0.120 |
Why?
|
Population Density | 1 | 2014 | 193 | 0.110 |
Why?
|
Vaccines, DNA | 2 | 2006 | 283 | 0.110 |
Why?
|
HIV | 2 | 2014 | 1580 | 0.110 |
Why?
|
Adaptation, Biological | 1 | 2014 | 147 | 0.110 |
Why?
|
Deficiency Diseases | 1 | 2013 | 74 | 0.110 |
Why?
|
HLA-B Antigens | 1 | 2014 | 317 | 0.110 |
Why?
|
Herpesvirus 2, Human | 2 | 2011 | 191 | 0.100 |
Why?
|
Immunity, Humoral | 1 | 2016 | 600 | 0.100 |
Why?
|
DNA, Viral | 4 | 2006 | 2194 | 0.100 |
Why?
|
T-Lymphocytes | 2 | 2006 | 10175 | 0.100 |
Why?
|
Phylogeny | 4 | 2014 | 2805 | 0.100 |
Why?
|
RNA, Viral | 4 | 2011 | 2838 | 0.100 |
Why?
|
CD4 Lymphocyte Count | 8 | 2016 | 2567 | 0.090 |
Why?
|
Selenium | 1 | 2013 | 417 | 0.090 |
Why?
|
Virology | 1 | 2010 | 75 | 0.090 |
Why?
|
Virus Internalization | 2 | 2012 | 497 | 0.090 |
Why?
|
Genetic Variation | 3 | 2021 | 6561 | 0.090 |
Why?
|
Host-Pathogen Interactions | 2 | 2016 | 1454 | 0.090 |
Why?
|
Valine | 1 | 2011 | 408 | 0.080 |
Why?
|
Base Sequence | 4 | 2014 | 12420 | 0.080 |
Why?
|
Antiviral Agents | 2 | 2011 | 3037 | 0.070 |
Why?
|
Cluster Analysis | 1 | 2014 | 2703 | 0.070 |
Why?
|
Deltaretrovirus | 1 | 1986 | 162 | 0.070 |
Why?
|
Gene Products, nef | 1 | 2006 | 100 | 0.070 |
Why?
|
Evolution, Molecular | 1 | 2014 | 1880 | 0.070 |
Why?
|
HIV Core Protein p24 | 1 | 2006 | 245 | 0.060 |
Why?
|
Drug Resistance, Viral | 1 | 2011 | 861 | 0.060 |
Why?
|
Schistosomiasis mansoni | 1 | 2006 | 94 | 0.060 |
Why?
|
Vitamins | 1 | 2013 | 1635 | 0.060 |
Why?
|
Antibodies, Viral | 2 | 2005 | 3149 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2020 | 4524 | 0.060 |
Why?
|
HIV Antibodies | 4 | 2016 | 1302 | 0.050 |
Why?
|
Adenoviruses, Human | 1 | 2005 | 255 | 0.050 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 2021 | 8 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12661 | 0.050 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1994 | 2149 | 0.050 |
Why?
|
Adaptor Protein Complex beta Subunits | 1 | 2021 | 13 | 0.050 |
Why?
|
Adaptor Protein Complex 3 | 1 | 2021 | 17 | 0.050 |
Why?
|
Saliva | 1 | 1986 | 828 | 0.050 |
Why?
|
Capsid Proteins | 1 | 2005 | 464 | 0.050 |
Why?
|
AIDS Vaccines | 2 | 2006 | 896 | 0.050 |
Why?
|
Senegal | 3 | 1999 | 255 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2013 | 3412 | 0.040 |
Why?
|
Peptide Fragments | 4 | 2012 | 5109 | 0.040 |
Why?
|
Sequence Analysis, DNA | 3 | 2014 | 4739 | 0.040 |
Why?
|
Neutralization Tests | 2 | 2016 | 725 | 0.040 |
Why?
|
Viral Vaccines | 1 | 2005 | 595 | 0.040 |
Why?
|
Honduras | 1 | 1999 | 37 | 0.040 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2020 | 1894 | 0.040 |
Why?
|
HIV Long Terminal Repeat | 1 | 1999 | 85 | 0.040 |
Why?
|
Seroepidemiologic Studies | 2 | 2014 | 398 | 0.040 |
Why?
|
Genetic Diseases, Inborn | 1 | 2004 | 604 | 0.040 |
Why?
|
Adult | 15 | 2020 | 220995 | 0.040 |
Why?
|
Linkage Disequilibrium | 1 | 2004 | 1994 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2006 | 1834 | 0.040 |
Why?
|
Humans | 28 | 2021 | 760740 | 0.040 |
Why?
|
Serotyping | 1 | 1999 | 325 | 0.040 |
Why?
|
Haplotypes | 1 | 2004 | 2713 | 0.040 |
Why?
|
HIV Seropositivity | 2 | 1999 | 959 | 0.030 |
Why?
|
Amino Acid Sequence | 5 | 2012 | 13442 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2004 | 4611 | 0.030 |
Why?
|
Viral Tropism | 1 | 2016 | 102 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2005 | 3392 | 0.030 |
Why?
|
Receptors, CCR5 | 2 | 2012 | 486 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2012 | 2747 | 0.030 |
Why?
|
Guinea-Bissau | 1 | 1994 | 5 | 0.030 |
Why?
|
Sequence Alignment | 1 | 1999 | 2178 | 0.030 |
Why?
|
Young Adult | 3 | 2020 | 59191 | 0.030 |
Why?
|
Prevalence | 3 | 2020 | 15702 | 0.030 |
Why?
|
Amino Acid Substitution | 2 | 2011 | 1739 | 0.030 |
Why?
|
Genotype | 2 | 2021 | 12977 | 0.030 |
Why?
|
Middle Aged | 7 | 2020 | 220603 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2802 | 0.030 |
Why?
|
Female | 17 | 2020 | 392203 | 0.020 |
Why?
|
Parity | 1 | 1994 | 924 | 0.020 |
Why?
|
Virulence | 1 | 2014 | 1299 | 0.020 |
Why?
|
Adolescent | 2 | 2020 | 88247 | 0.020 |
Why?
|
HIV Reverse Transcriptase | 1 | 2011 | 212 | 0.020 |
Why?
|
Sexual Partners | 1 | 1994 | 800 | 0.020 |
Why?
|
South Africa | 1 | 2014 | 1843 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4408 | 0.020 |
Why?
|
Luciferases | 1 | 2010 | 712 | 0.020 |
Why?
|
Virus Replication | 1 | 2016 | 2427 | 0.020 |
Why?
|
Kenya | 1 | 2011 | 757 | 0.020 |
Why?
|
Polymerase Chain Reaction | 4 | 1999 | 6074 | 0.020 |
Why?
|
Peru | 1 | 2011 | 890 | 0.020 |
Why?
|
Disease Progression | 3 | 2013 | 13495 | 0.020 |
Why?
|
Mice, Inbred BALB C | 2 | 2006 | 6188 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 22131 | 0.020 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 2006 | 148 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2010 | 1525 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2011 | 868 | 0.020 |
Why?
|
p21-Activated Kinases | 1 | 2006 | 127 | 0.020 |
Why?
|
Point Mutation | 1 | 2011 | 1595 | 0.020 |
Why?
|
Male | 9 | 2020 | 360402 | 0.020 |
Why?
|
Plasmids | 1 | 2010 | 2265 | 0.020 |
Why?
|
Cohort Studies | 4 | 2014 | 41464 | 0.020 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2005 | 359 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2004 | 15908 | 0.010 |
Why?
|
Immunodominant Epitopes | 1 | 2005 | 238 | 0.010 |
Why?
|
Mass Screening | 1 | 2020 | 5425 | 0.010 |
Why?
|
Anti-Retroviral Agents | 1 | 2013 | 1783 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2006 | 927 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9345 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14599 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6305 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6473 | 0.010 |
Why?
|
Prospective Studies | 4 | 2011 | 54364 | 0.010 |
Why?
|
DNA Primers | 2 | 1999 | 2817 | 0.010 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2006 | 825 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2004 | 783 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2011 | 2570 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2006 | 3074 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 1994 | 12043 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 1994 | 7805 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2010 | 14649 | 0.010 |
Why?
|
Chemokines, CC | 1 | 2000 | 283 | 0.010 |
Why?
|
Genetics, Population | 1 | 2004 | 935 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2006 | 1779 | 0.010 |
Why?
|
Genetic Markers | 1 | 2004 | 2601 | 0.010 |
Why?
|
Age Factors | 1 | 1994 | 18381 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1998 | 777 | 0.010 |
Why?
|
HIV Antigens | 1 | 1998 | 325 | 0.010 |
Why?
|
Gene Frequency | 1 | 2004 | 3601 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21339 | 0.010 |
Why?
|
Case-Control Studies | 1 | 1994 | 22153 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 15577 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2010 | 12333 | 0.010 |
Why?
|
Immunoblotting | 1 | 1998 | 1646 | 0.010 |
Why?
|
Alleles | 1 | 2004 | 6861 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13635 | 0.010 |
Why?
|
Pregnancy | 1 | 1994 | 29869 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4569 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2005 | 4172 | 0.010 |
Why?
|
Algorithms | 1 | 2012 | 14024 | 0.010 |
Why?
|
Genome, Human | 1 | 2004 | 4421 | 0.010 |
Why?
|
Brain | 1 | 1996 | 27100 | 0.010 |
Why?
|
Mice | 2 | 2006 | 81368 | 0.000 |
Why?
|
Risk Factors | 1 | 1994 | 74128 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2013 | 64572 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2005 | 22117 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1999 | 7583 | 0.000 |
Why?
|
Survival Rate | 1 | 1999 | 12719 | 0.000 |
Why?
|
Animals | 2 | 2006 | 168202 | 0.000 |
Why?
|
United States | 1 | 2011 | 72292 | 0.000 |
Why?
|
Time Factors | 1 | 1999 | 39908 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1995 | 39062 | 0.000 |
Why?
|